XGN Stock Analysis: Buy, Sell, or Hold?
XGN - Exagen Inc. Common Stock
$7.92
0.14 (1.80%)
▲
5d:
+18.92%
30d:
+60.0%
90d:
+85.48%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When XGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: XGN is 25.1% above its trading range ($6.33). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: XGN is 25.1% above its trading range ($6.33). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: XGN is currently trading at $7.92, which is considered extended relative to its 30-day fair value range of $4.24 to $6.33.
Technical Outlook: Technically, XGN is in a strong uptrend. The price is approaching resistance at $7.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.86 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XGN is in a strong uptrend. The price is approaching resistance at $7.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.86 (+24.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.24 -
$6.33
Company Quality Score
40/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
15.8%
All Signals
- BEARISH: Price significantly overextended (+25.1% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.5% below Wall St target ($9.86)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.24 -
$6.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.49
Resistance Level
$7.99
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.00
Wall Street Target
$9.86
(+24.5%)
Revenue Growth (YoY)
15.9%
Profit Margin
-26.6%
Share & Embed Analysis
Last updated: August 22, 2026 4:58 PM ET
Data refreshes hourly during market hours. Next update: 5:58 PM
Data refreshes hourly during market hours. Next update: 5:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
John Aballi
SELL
15698 shares
2026-03-03
John Aballi
SELL
11430 shares
2026-02-24
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 43 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$331 | 38 SELL |
